Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New SERD discovered by dynamics simulation shows promise for breast cancer therapy

July 30, 2021

Reyoung divulges new autophagy inhibitors

July 30, 2021

New DNA-dependent protein kinase inhibitors identified at Chengdu Baiyu Pharmaceutical

July 30, 2021

Dizal (Jiangsu) Pharmaceutical discovers Bruton tyrosine kinase inhibitors

July 30, 2021

Blueprint Medicines and MD Anderson collaborate on advancing CDK2 inhibitor BLU-222

July 29, 2021

FDA clears INDs for targeted alpha therapy FPI-1966 and imaging agent FPI-1967

July 29, 2021

Clarity initiates phase I/IIa theranostic trial of 64/67Cu SAR-bisPSMA in metastatic CRPC

July 29, 2021

Targeting the IL-8/CXCR2 axis as a potential therapeutic strategy in prostate cancer

July 29, 2021

New serine-protein kinase ATM inhibitors described by Medshine Discovery

July 29, 2021

First patients dosed in new studies of Xpovio in melanoma and myelofibrosis

July 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...